These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30251395)

  • 1. Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
    Makena MR; Cho HE; Nguyen TH; Koneru B; Verlekar DU; Hindle A; Kang MH; Reynolds CP
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27447. PubMed ID: 30251395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
    Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
    Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
    Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
    Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
    Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
    Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas.
    Broaddus RR; Xie S; Hsu CJ; Wang J; Zhang S; Zou C
    Am J Obstet Gynecol; 2004 Mar; 190(3):686-92. PubMed ID: 15042000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DFMO inhibition of neuroblastoma tumorigenesis.
    Gandra D; Mulama DH; Foureau DM; McKinney KQ; Kim E; Smith K; Haw J; Nagulapally A; Saulnier Sholler GL
    Cancer Med; 2024 May; 13(9):e7207. PubMed ID: 38686627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma.
    Schultz CR; Swanson MA; Dowling TC; Bachmann AS
    Cancer Chemother Pharmacol; 2021 Oct; 88(4):607-617. PubMed ID: 34129075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
    Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
    BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
    Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
    Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.
    Nguyen TH; Koneru B; Wei SJ; Chen WH; Makena MR; Urias E; Kang MH; Reynolds CP
    Mol Cancer Ther; 2019 Dec; 18(12):2270-2282. PubMed ID: 31484706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.
    Fang H; Harned TM; Kalous O; Maldonado V; DeClerck YA; Reynolds CP
    Clin Cancer Res; 2011 Nov; 17(22):7093-104. PubMed ID: 21933888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
    Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
    Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
    Cooper JP; Reynolds CP; Cho H; Kang MH
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.
    Lovat PE; Oliverio S; Corazzari M; Rodolfo C; Ranalli M; Goranov B; Melino G; Redfern CP; Piacentini M
    Cancer Res; 2003 Nov; 63(21):7310-3. PubMed ID: 14612528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
    Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N
    J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
    Bassiri H; Benavides A; Haber M; Gilmour SK; Norris MD; Hogarty MD
    Transl Pediatr; 2015 Jul; 4(3):226-38. PubMed ID: 26835380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.